Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Sep;28(6):907-13.
doi: 10.1007/s10571-008-9278-x. Epub 2008 Apr 1.

Cyclin D1 immunoreactivity in meningiomas

Sanja Milenković  1 , Tatjana Marinkovic, Milan B Jovanovic, Slavisa Djuricic, Ivana I Berisavac, Iva Berisavac
Affiliations

Cyclin D1 immunoreactivity in meningiomas

Sanja Milenković et al. Cell Mol Neurobiol. 2008 Sep.

Abstract

Objective: Cyclin D1 is an important nuclear protein required for progression of cells through the G1 phase of the cell cycle. The proliferative potential of meningiomas has been studied using various proliferative markers. However, there have been only few published studies evaluating Cyclin D1 immunoreactivity in meningiomas.

Purpose of the study: The aim of our study was to analyze the Cyclin D1 expression in meningiomas and correlate it both with proliferation markers Ki67 and PCNA, and with meningiomas of WHO grade.

Material and methods: We evaluated immunoreactivity for proliferative markers (Cyclin D1, Ki-67, and PCNA) in a consecutive series of 64 meningioma samples obtained from patients who underwent surgical resection because of cerebral or spinal meningiomas. Immunohistochemical staining with Ki-67, PCNA, and Cyclin D1 was performed using the microwave processing procedure and LSAB+ methodology. The number of positive cells for each antibody has been determined and shown in percentage in relation to 1000 counted cells.

Results: All meningioma samples showed immunostaining for Ki-67, PCNA, and Cyclin D1 antibodies. The Cyclin D1 scores exhibited a close correlation with Ki-67 and PCNA immunostaining (P < 0.01). Some meningiomas (15 cases) showed a combination of nuclear and cytoplasmatic (fine granular) Cyclin D1 immunoreactivity. All proliferative indexes have been in positive correlation with meningioma grade.

Conclusion: Our comparative study of proliferative markers in meningiomas demonstrated Cyclin D1 as a very useful proliferative marker in meningiomas.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
(a) Nuclear anti-Ki67 positive staining in meningothelial meningioma (Immunoperoxidase 40×). (b) Nuclear anti-PCNA (⇦) and “ring” shape (←) positive staining in meningothelial meningioma (Immunoperoxidase 40×). (c) Nuclear anti-cyclin D1 positive staining in meningothelial meningioma (Immunoperoxidase 40×)
Fig. 2
Fig. 2
Nuclear (←) and “ring” (⇦) anti-cyclin D1 positive staining in meningothelial meningioma (Immunoperoxidase 40×)
Fig. 3
Fig. 3
Nuclear and cytoplasmatic granular (⇦) anti-cyclin D1 positive staining in malignant meningioma (Immunoperoxidase 40×)
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Abramovich CM, Prayson RA (1998) MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors. Hum Pathol 29:1420–1427 - PubMed
    1. Alama A, Barbieri B, Spaziante R, Bruzzo C, Dadati P, Dorcaratto A (2007) Significance of cyclin D1 expression in meningiomas. A preliminary study. J Clin Neurosci 14:355–358 - PubMed
    1. Alt JR, Gladden AB, Diehl JA (2001) p21cip1 promotes cyclin D1 nuclear accumulation via direct inhibition of nuclear export. J Biol Chem 277:8517–8523 - PubMed
    1. Amatya JV, Takeshima Y, Sugiyama K, Kurisu K, Nishisaka T, Fukuhara T, Inai K (2001) Immunohistochemical study of Ki-67 (MIB-1), p53 Protein, p21WAF1, and p27KIP1 expression in Benign, atypical, and anaplastic meningiomas. Hum Pathol 32(9):970–975 - PubMed
    1. Arber N, Gammon MD, Hibshoosh H, Britton JA, Zhang Y, Schonberg JB, Roterdam H, Fabian I, Holt PR, Weinstein B (1999) Overexpression of cyclin D1 occurs in both squamous carcinomas and adenocarcinomas of the esophagus and in adenocarcinomas of the stomach. Hum Pathol 30:1087–1092 - PubMed